- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Emcure Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter and half-year. Mr. Anil Kothiyal, President – India Sales & Marketing, has resigned effective June 6, 2025, citing personal reasons. This leadership change in a crucial role overseeing India sales and marketing may influence Emcure’s strategic approach in its key domestic market, potentially affecting its growth momentum and stakeholder confidence.